ANAPTYSBIO, INC (ANAB) › Operating Cash FlowANAPTYSBIO, INC (ANAB) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: -$9.69M2016: -$9.03M2017: -$19.44M2018: -$48.51M2019: -$69.52M2020: -$14.16M2021: -$45.92M2022: -$73.59M2023: -$120.80M2024: -$135.34M2025: $19.70M$19.70M2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$19.70M+114.6%2024-$135.34M-12.0%2023-$120.80M-64.1%2022-$73.59M-60.3%2021-$45.92M-224.4%2020-$14.16M+79.6%2019-$69.52M-43.3%2018-$48.51M-149.5%2017-$19.44M-115.3%2016-$9.03M+6.8%2015-$9.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share